Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Ying-zhong Lin"'
Autor:
Lei Shi, MD, Ying-zhong Lin, MD, Ling Liu, MD, Zhengde Lu, MD, Changxi Hu, MD, PhD, Qingwei Ji, MD, PhD
Publikováno v:
HeartRhythm Case Reports, Vol 7, Iss 11, Pp 745-749 (2021)
Externí odkaz:
https://doaj.org/article/c19647dbf4c84684b6c0bcdb0fa59268
Autor:
Ying-zhong Lin, Shan-he Lu, Zheng-de Lu, Ying Huang, Ying Shi, Ling Liu, Xiao-yan Wang, Qing-wei Ji
Publikováno v:
Mediators of Inflammation, Vol 2013 (2013)
Background. Regulatory T (Treg) cells play a protective role in atherosclerosis prone models and are related to the onset of acute coronary syndromes (ACS, including non-ST-elevation ACS (NSTEACS) and ST-elevation acute myocardial infarction (STEAMI)
Externí odkaz:
https://doaj.org/article/4ce57ffa82a84d129f927bc6f3669af5
Autor:
Ying-zhong Lin, Bang-wei Wu, Zheng-de Lu, Ying Huang, Ying Shi, Hao Liu, Ling Liu, Qiu-tang Zeng, Xiang Wang, Qing-wei Ji
Publikováno v:
Mediators of Inflammation, Vol 2013 (2013)
Background. CD4+ T helper (Th) cells play critical roles in the development and progression of atherosclerosis and the onset of acute coronary syndromes (ACS, including acute myocardial infarction (AMI) and unstable angina pectoris (UAP)). In additio
Externí odkaz:
https://doaj.org/article/79556b67e2e5430b92e07e87de14934c
Autor:
YING-ZHONG LIN1, JING-BIN HUANG1,2 b2007117@hotmail.com, XIANG-WEI LI1, XIAN-MING TANG1, WEI-JUN LU1, ZHAO-KE WEN1, JIAN LIANG2, DIAN-YUAN LI3, HAO WANG1
Publikováno v:
Experimental & Therapeutic Medicine. Sep2017, Vol. 14 Issue 3, p2677-2682. 6p.
Autor:
Lei, Shi, Qingwei, Ji, Ling, Liu, Ying, Shi, Zhengde, Lu, Jing, Ye, Tao, Zeng, Yan, Xue, Zicong, Yang, Yu, Liu, Jianyong, Lu, Xinshun, Huang, Qiuwen, Qin, Tianzhu, Li, Ying-Zhong, Lin
Publikováno v:
Journal of Cellular and Molecular Medicine
Th22 cells are a novel subset of CD4+ T cells that primarily mediate biological effects through IL‐22, with both Th22 cells and IL‐22 being closely associated with multiple autoimmune and chronic inflammatory diseases. In this study, we investiga
Autor:
Lei Shi, Qingwei Ji, Ling Liu, Ying Shi, Zhengde Lu, Jing Ye, Tao Zeng, Yan Xue, Zicong Yang, Yu Liu, Jianyong Lu, Xinshun Huang, Qiuwen Qin, Tianzhu Li, Ying-zhong Lin
Publikováno v:
SSRN Electronic Journal.
Autor:
Rui-ping Zhao, Yi-shi Li, Ying-zhong Lin, Guo-liang Chen, Chao-mei Fan, Jing Yu, Shi-yao Wu, Hui-min Pang, Hui-min Li, Lirong Yan, Li Wang
Publikováno v:
Journal of Cardiovascular Pharmacology. 60:8-14
This is a multicenter, randomized, double-blind, parallel-controlled study, conducted in Chinese patients with mild to moderate essential hypertension. After a 2-week washout period, 236 eligible patients were randomly to receive aranidipine 5-10 mg/
Autor:
Hao Wang, Wei‑Jun Lu, Xian‑Ming Tang, Jian Liang, Dian‑Yuan Li, Ying‑Zhong Lin, Jing‑Bin Huang, Zhao‑Ke Wen, Xiang‑Wei Li
Publikováno v:
Experimental and therapeutic medicine. 14(3)
Cardioplegic reperfusion during a long-term ischemic period interrupts cardiac surgery and increases cellular edema due to repeated administration. The present clinical study compared the protective effects of histidine-ketoglutarate-tryptophan (HTK)
Autor:
Hong, Wang, Lin, Wang, Ling, Liu, Ying-zhong, Lin, You-qiong, Li, Hong-mei, Lu, Guo-ping, Gong
Publikováno v:
Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue. 24(12)
To explore the role of microRNA-92a (miR-92a) in evaluating endothelium damage induced by percutaneous coronary intervention (PCI).A case control study was prospectively conducted. Fifty-eight patients with ST-segment elevation acute myocardial infar
Autor:
Hong, Wang, Hong-mei, Lu, Wen-hui, Yang, Cheng, Luo, Shan-he, Lu, Ying, Zhou, Ying-zhong, Lin
Publikováno v:
Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue. 24(4)
To investigate the modulatory function of statin therapy on circulating microRNA-92a (miR-92a) in patients with coronary heart disease (CHD), and to evaluate the possibility of miR-92a as a new target of treatment for endothelial dysfunction.A case c